U.S. FDA Grants 510(k) Expanded Indication for Palliare’s EVA15 Insufflation Technology to Accommodate Higher Pressure Range.
31 January 2023. Galway, Ireland and Oceanside, California, USA. Palliare, a leading developer of advanced insufflation technologies, has received an expanded 510(k) indication from the U.S. Food and Drug Administration for its EVA15 Insufflator to provide an extended pressure delivery range of up to 25mmHg. This increased pressure range represents the highest-performing robotic insufflator on […]
